Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOFSTAT: Tofacitinib and Statins vs TNF Inhibitors in Rheumatoid Arthritis
NCT07554820Phase 4Recruiting
- Sponsor
- Shaikh Zayed Hospital
- Start
- Dec 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tofacitinib in rheumatoid arthritis (RA) (2 arms), sponsored by Shaikh Zayed Hospital. Primary endpoints: Major Adverse Cardiovascular Event at 6 months and Compare Incidence of MACE in two group at 6 months. Started Dec 2025; status: recruiting.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07554820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07554820.